- July 7, 2023In re Entresto Patent Litigation
- July 6, 2023Artistry No Excuse for Trademark Infringement Where Use is Source Identifying
- July 6, 2023Novartis Pharms. Corp. v. Mylan Pharms. Inc.
- July 2023The Sedona Conference Commentary on the Governance and Management of Trade Secrets
- Sanofi-Aventis U.S. LLC v. Sandoz, Inc.
- June 2023On the Emotional Costs of Litigation
- June 2023Chaos v. Predictability: The Enforceability of Choice of Law Provisions
- June 2023Attorney Spotlight: Partner Christina M. Lincoln
- June 2023I Love Insurance and My Dog: Pet Insurance 101
- June 2023Understanding Fiduciary Duties and Obligations in Investment and Divestment
- June 2023Top Five Writing Tips for Everyday Writing
- June 2023The Blame Game: Can Cyber Crimes Fall Under the War Exclusion?
- June 2023Lessons from the Trial Trenches: How to Avoid Large Adverse Verdicts
- June 2023Marina Pacific: A Rare Glimpse into a Pandemic-Related Property Coverage Trial
- June 9, 2023Astellas Pharma Inc. v. Sandoz Inc.
- May 2023Raoul Shah: Keeping Humanity and Compassion Close
- Janssen Pharms., Inc. v. Mylan Labs. Ltd.
- 2023 Bulletin - First QuarterGENERICally Speaking: A Hatch-Waxman Litigation Bulletin 2023 Q1
- In re Sugammadex
- Vanda Pharms. Inc. v. Teva Pharms. USA, Inc.
- Azurity Pharms., Inc. v. Alkem Labs. Ltd.
- Bristol-Myers Squibb Co. v. Xspray Pharma AB
- Drafting Subsequent Agreements to Avoid Arbitrability Litigation
- Amgen Inc. v. Sandoz Inc.
- March 2023Achieving the Largest Jury Verdict in Minnesota History
- UCB, Inc. v. Actavis Labs. UT, Inc.
- First QuarterANDA Approvals
- First QuarterANDA Litigation Settlements
- Purdue Pharma L.P. v. Accord Healthcare Inc.
- First QuarterGeneric Launches
- First QuarterNew ANDA Cases
- Bristol-Myers Squibb Co. v. Nanocopoeia, LLC
- March 2023Unintended Consequences of Banning Noncompete Agreements
- What I’ll Be Watching for in the Amgen Oral Arguments
- March 2023Should you take financial advice from Magnum P.I.?
- March 2023When Lending a Hand Results in Liability
- March 2023How an Investor Can Lose More Than Just Their Investment
- March 2023When Lending a Hand Results in Liability
- March 2023Should you take financial advice from Magnum P.I.?
- Feb. 24, 2023Jazz Pharms., Inc. v. Avadel CNS Pharms.
- A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
- February 7, 2023When Monkey Business Slips Into Trademark Infringement
- Feb. 10, 2023Azurity Pharms., Inc. v. Alkem Labs. Ltd.
- Feb. 10, 2023Vanda Pharms. Inc. v. Teva Pharms. USA, Inc.
- Fourth QuarterANDA Approvals
- Briefly: Column to Continue With New Authors at Helm
- Jan. 19, 2023Exelixis, Inc. v. MSN Labs. Private Ltd.
- Jan. 6, 2023Azurity Pharms., Inc. v. Bionpharma Inc.
- January 2023Robins Kaplan Pursuing Camp Lejeune Claims
- January 2023Rayna Kessler Appointed Liaison Counsel in Exactech Multi-District Litigation
